UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of chelation therapy on survival in transfusional iron overload: a meta‐analysis of myelodysplastic syndrome

British journal of haematology, 2014-12, Vol.167 (5), p.720-723

2014

Volltextzugriff (PDF)

LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study

Lancet neurology, 2008-07, Vol.7 (7), p.591-594

2008

Volltextzugriff (PDF)

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

Parkinsonism & related disorders, 2007-03, Vol.13 (2), p.89-92

2007

Volltextzugriff (PDF)

Public Health Surveillance of Nonmalignant Blood Disorders

American journal of preventive medicine, 2014-11, Vol.47 (5), p.664-668

2014

Volltextzugriff (PDF)

Lrrk2 pathogenic substitutions in Parkinson's disease

Neurogenetics, 2005-12, Vol.6 (4), p.171-177

2005

Volltextzugriff (PDF)

Attitudes toward Management of Sickle Cell Disease and Its Complications: A National Survey of Academic Family Physicians

Anemia, 2015-01, Vol.2015 (2015), p.99-104

2015

Volltextzugriff (PDF)

Transferrin Saturation and Hospital Length of Stay and Mortality in Medicare Beneficiaries

Journal of the American Geriatrics Society (JAGS), 2013-01, Vol.61 (1), p.132-136

2013

Volltextzugriff (PDF)

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008

Public health reports (1974), 2016-03, Vol.131 (2), p.367-375

2016

Volltextzugriff (PDF)

Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project

British journal of haematology, 2021-12, Vol.195 (5), p.e160-e164

2021

Volltextzugriff (PDF)

Providers' Perspectives on Treating Patients With Thalassemia

Journal of pediatric hematology/oncology, 2019-10, Vol.41 (7), p.e421-e426

2019

Volltextzugriff (PDF)

Genomic investigation of α-synuclein multiplication and parkinsonism

Annals of neurology, 2008-06, Vol.63 (6), p.743-750

2008

Volltextzugriff (PDF)

Emergency department utilization by Californians with sickle cell disease, 2005–2014

Pediatric blood & cancer, 2017-06, Vol.64 (6), p.np-n/a

2017

Volltextzugriff (PDF)

Genomewide Association, Parkinson Disease, and PARK10

American journal of human genetics, 2006-06, Vol.78 (6), p.1084-1088

2006

Volltextzugriff (PDF)

DCTN1 mutations in Perry syndrome

Nature genetics, 2009-02, Vol.41 (2), p.163-165

2009

Volltextzugriff (PDF)

The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia

Genetics in medicine, 2014-01, Vol.16 (1), p.33-39

2014

Volltextzugriff (PDF)

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease

JAMA : the journal of the American Medical Association, 2006-08, Vol.296 (6), p.661

2006

Volltextzugriff (PDF)

Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005-2016

Pediatric hematology and oncology, 2020-11, Vol.37 (8), p.747-751

2020

Volltextzugriff (PDF)

Fine-mapping and candidate gene investigation within the PARK10 locus

European journal of human genetics : EJHG, 2009-03, Vol.17 (3), p.336-343

2009

Volltextzugriff (PDF)

State-based surveillance for selected hemoglobinopathies

Genetics in medicine, 2015-02, Vol.17 (2), p.125-130

2015

Volltextzugriff (PDF)

Effectiveness of Clinical Decision Support Based Intervention in the Improvement of Care for Adult Sickle Cell Disease Patients in Primary Care

Journal of the American Board of Family Medicine, 2018-09, Vol.31 (5), p.812-816

2018

Volltextzugriff (PDF)

Incidence of Sickle Cell Trait — United States, 2010

MMWR. Morbidity and mortality weekly report, 2014-12, Vol.63 (49), p.1155-1158

2014

Volltextzugriff (PDF)

Public health implications of sickle cell trait: a report of the CDC meeting

American journal of preventive medicine, 2011-12, Vol.41 (6 Suppl 4), p.S435-S439

2011

Volltextzugriff (PDF)

Leucine-rich repeat kinase 1 : a paralog of LRRK2 and a candidate gene for Parkinson's disease

Neurogenetics, 2007-04, Vol.8 (2), p.95-102

2007

Volltextzugriff (PDF)

Elevated transferrin saturation, health-related quality of life and telomere length

Biometals, 2014-02, Vol.27 (1), p.135-141

2014

Volltextzugriff (PDF)

Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease

Movement disorders, 2007-02, Vol.22 (3), p.389-392

2007

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(66)
Berichte
(2)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(57)
Male
(46)
Female
(44)
Middle Aged
(33)
Adult
(30)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Aged
(24)
Neurology
(23)
Neurosciences & Neurology
(23)
Parkinson Disease - Genetics
(23)
Mutation
(19)
Clinical Neurology
(18)
Parkinson's Disease
(16)
Genetics & Heredity
(14)
Aged, 80 And Over
(13)
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
(11)
Pedigree
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of chelation therapy on survival in transfusional iron overload: a meta‐analysis of myelodysplastic syndrome

LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

Public Health Surveillance of Nonmalignant Blood Disorders

Lrrk2 pathogenic substitutions in Parkinson's disease

Attitudes toward Management of Sickle Cell Disease and Its Complications: A National Survey of Academic Family Physicians

Transferrin Saturation and Hospital Length of Stay and Mortality in Medicare Beneficiaries

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008

Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project

Providers' Perspectives on Treating Patients With Thalassemia

Genomic investigation of α-synuclein multiplication and parkinsonism

Emergency department utilization by Californians with sickle cell disease, 2005–2014

Genomewide Association, Parkinson Disease, and PARK10

DCTN1 mutations in Perry syndrome

The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease

Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005-2016

Fine-mapping and candidate gene investigation within the PARK10 locus

State-based surveillance for selected hemoglobinopathies

Effectiveness of Clinical Decision Support Based Intervention in the Improvement of Care for Adult Sickle Cell Disease Patients in Primary Care

Incidence of Sickle Cell Trait — United States, 2010

Public health implications of sickle cell trait: a report of the CDC meeting

Leucine-rich repeat kinase 1 : a paralog of LRRK2 and a candidate gene for Parkinson's disease

Elevated transferrin saturation, health-related quality of life and telomere length

Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease

Suchergebnisse filtern